Page 2 - Bioconnect Trusted Identity Service News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioconnect trusted identity service. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioconnect Trusted Identity Service Today - Breaking & Trending Today

NeonMind Biosciences Inc.: NeonMind to Present at H.C. Wainwright Bioconnect Conference

VANCOUVER, BC / ACCESSWIRE / January 6, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company, announced today ....

British Columbia , Rob Tessarolo , Hc Wainwright Bioconnect , Scott Eckstein Tim Regan , Robert Tessarolo , Strategic Communications , Neonmind Biosciences Inc , Canadian Securities Exchange , Neonmind Biosciences , Chief Executive Officer , Bioconnect Conference , Bioconnect Conference Details ,

Neovasc Inc.: Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference

Vancouver, British Columbia and Minneapolis, Minnesota (Newsfile Corp. - January 6, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that its management team ....

United States , United Kingdom , British Columbia , Mike Cavanaugh , Sean Leous , Fred Colen , Company Annual Report On Form , Minnesota Newsfile Corp , Neovasc Inc , Chief Executive Officer , Neovasc Reducer , Securities Litigation Reform Act , Annual Report ,

Viewpoint Molecular Targeting, Inc.: Viewpoint Molecular Targeting to Present at the H.C. Wainwright BioConnect Conference

CORALVILLE, IA / ACCESSWIRE / January 5, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle oncology ....

Jenene Thomas , Kostenloser Wertpapierhandel , Francesl Johnson , Hc Wainwright Bioconnect , Viewpoint Molecular Targeting Inc , Company Melanoma , Viewpoint Molecular Targeting , Chief Executive Officer , Bioconnect Conference , Molecular Targeting , Neuroendocrine Tumor , Investor Inquiries ,

Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference

Salt Lake City, Utah (Newsfile Corp. - January 5, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) will participate in the H.C. Wainwright Bioconnect Virtual Conference January 10-13, 2022. Brian Strem ....

Salt Lake City , United States , Francina Agosti , Hc Wainwright Bioconnect , Brian Strem , Utah Newsfile Corp , Company Investor Relations , Kiora Pharmaceuticals Inc , Bioconnect Virtual Conference January , Chief Executive Officer , Investor Relations , Monday January , Dihydroorotate Dehydrogenase , Private Securities Litigation Reform Act , Annual Report ,

Dermata Therapeutics: Dermata to Present at the H.C. Wainwright BioConnect Conference

SAN DIEGO, CA / ACCESSWIRE / January 5, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic ....

United States , San Diego , Gerry Proehl , Sean Proehl , Hc Wainwright Bioconnect , Wendell Wierenga , Exchange Commission , Dermata Therapeutics Inc , Dermata Therapeutics , Business Development , Chief Executive Officer , Bioconnect Virtual Conference , Investor Relations , Private Securities Litigation Reform Act ,